However, Nrf2 is upregulated in human colorectal tumors and correlates with poor patient prognosis22, and thus it is probable that Nrf2 activation occurs later in the carcinogenesis process, such as during transition from adenoma to adenocarcinoma, supporting tumor growth. This evidence concerns the gene NFE2L2 and adenocarcinoma.